{"id":"spectinomycin","_chembl":{"chemblId":"CHEMBL3989571","moleculeType":"Small molecule","molecularWeight":"495.35"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SPECTINOMYCIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:17:30.245929+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:17:37.354197+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SPECTINOMYCIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:17:38.837046+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Bacterial 70S ribosome inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:17:39.405380+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989571/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:17:39.311763+00:00"}},"_dailymed":{"setId":"388df4c8-35e4-4ad4-8b56-66a9ae78432d","title":"L-S 50 (LINCOMYCIN HYDROCHLORIDE AND SPECTINOMYCIN SULFATE TETRAHYDRATE) POWDER, FOR SOLUTION [PHIBRO ANIMAL HEALTH]"},"_scrapedAt":"2026-03-27T23:37:56.255Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:17:41.071324+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02653170","phase":"NA","title":"Michigan Stroke Transitions Trial","status":"COMPLETED","sponsor":"Michigan State University","startDate":"2016-01","conditions":"Acute Stroke","enrollment":320}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"BACK PAIN"},{"count":3,"reaction":"CHEST DISCOMFORT"},{"count":3,"reaction":"DRY MOUTH"},{"count":3,"reaction":"DYSPNOEA"},{"count":3,"reaction":"PANIC ATTACK"},{"count":3,"reaction":"PHARYNGEAL OEDEMA"},{"count":3,"reaction":"TREATMENT FAILURE"},{"count":2,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"OBLITERATIVE BRONCHIOLITIS"},{"count":2,"reaction":"PATHOGEN RESISTANCE"}],"crossReferences":{"chemblId":"CHEMBL3989571"},"_approvalHistory":[],"publicationCount":2602,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"approved","brandName":"SPECTINOMYCIN","genericName":"SPECTINOMYCIN","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1971","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:17:41.071324+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}